Intervention

external beam radiation therapy

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13
Recruiting0
Common conditions25
Lead sponsors shown12
Advertisement

Clinical trials

13 shown
Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)NCT02594072 · 2016-04-01
UNKNOWN
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation TherapyNCT02422498 · 2015-04-14
ACTIVE_NOT_RECRUITING
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate CancerNCT02280356 · 2014-10-28
COMPLETED
Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical CancerNCT01590017 · 2014-04-01
COMPLETED
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate CancerNCT01807065 · 2013-06-25
COMPLETED
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerNCT01407770 · 2011-09-20
COMPLETED
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate CancerNCT01023061 · 2010-03-01
COMPLETED
Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast CancerNCT01100489 · 2010-02-01
WITHDRAWN
Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical ModelNCT03979079 · 2010-01-01
COMPLETED
Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast CancerNCT00902668 · 2009-04-01
TERMINATED
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerNCT00943956 · 2009-01-01
COMPLETED
Observation or Radical Treatment in Patients With Prostate CancerNCT00499174 · 2007-12-06
TERMINATED
Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast CancerNCT00943410 · 2000-03-01
COMPLETED

Common conditions

Prostate Cancer5Breast Cancer3Adenocarcinoma of the Prostate2Radiation Toxicity2Stage IV Prostate Cancer2Acquired Immunodeficiency Syndrome1Bone Metastases1Cervical Cancer1Cognitive Ability, General1Ductal Breast Carcinoma in Situ1Estrogen Receptor-negative Breast Cancer1Estrogen Receptor-positive Breast Cancer1Fatigue1HER2-negative Breast Cancer1HER2-positive Breast Cancer1Hormone-resistant Prostate Cancer1Invasive Ductal Breast Carcinoma1Invasive Lobular Breast Carcinoma1Locally Recurrent/Metastatic Triple Negative Breast Cancer1Male Breast Cancer1Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate1Mucinous Ductal Breast Carcinoma1Pain1Papillary Ductal Breast Carcinoma1Progesterone Receptor-negative Breast Cancer1

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

prostate cancer5breast cancer3prostate adenocarcinoma2cervical cancer1ductal breast carcinoma in situ1estrogen-receptor negative breast cancer1estrogen-receptor positive breast cancer1HER2 positive breast carcinoma1hormone-resistant prostate carcinoma1invasive ductal breast carcinoma1invasive lobular breast carcinoma1male breast carcinoma1progesterone-receptor negative breast cancer1progesterone-receptor positive breast cancer1

Trial status mix

COMPLETED8
TERMINATED2
ACTIVE_NOT_RECRUITING1
UNKNOWN1
WITHDRAWN1

Phase mix

PHASE28
NA2
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.